These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15892085)

  • 1. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects.
    Ramlow W; Emmrich J; Ahrenholz P; Sparmann G; Kashiwagi N; Franz M; Yokoyama T; Yoshikawa T
    J Clin Apher; 2005 Jul; 20(2):72-80. PubMed ID: 15892085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
    Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
    J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-modulation of toll-like receptor 2 expression on granulocytes and suppression of interleukin-8 production due to in vitro treatment with cellulose acetate beads.
    Hidaka M; Fukuzawa K
    Ther Apher Dial; 2011 Dec; 15(6):572-8. PubMed ID: 22107694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.
    Saniabadi AR; Hanai H; Takeuchi K; Umemura K; Nakashima M; Adachi T; Shima C; Bjarnason I; Lofberg R
    Ther Apher Dial; 2003 Feb; 7(1):48-59. PubMed ID: 12921115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of uremia and hemodialysis on soluble L-selectin and leukocyte surface CD11b and L-selectin.
    Dou L; Brunet P; Dignat-George F; Sampol J; Berland Y
    Am J Kidney Dis; 1998 Jan; 31(1):67-73. PubMed ID: 9428454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.
    Kashiwagi N; Sugimura K; Koiwai H; Yamamoto H; Yoshikawa T; Saniabadi AR; Adachi M; Shimoyama T
    Dig Dis Sci; 2002 Jun; 47(6):1334-41. PubMed ID: 12064810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First human application of a novel adsorptive-type cytapheresis module in patients with active ulcerative colitis: a pilot study.
    Ramlow W; Waitz G; Sparmann G; Prophet H; Bodammer P; Emmrich J
    Ther Apher Dial; 2013 Jun; 17(3):339-47. PubMed ID: 23735151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils.
    Kanekura T; Hiraishi K; Kawahara K; Maruyama I; Kanzaki T
    Ther Apher Dial; 2006 Jun; 10(3):247-56. PubMed ID: 16817789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes.
    Furebring M; Håkansson L; Venge P; Sjölin J
    Scand J Immunol; 2006 Mar; 63(3):208-16. PubMed ID: 16499574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin.
    Takeda Y; Shiobara N; Saniabadi AR; Adachi M; Hiraishi K
    Inflamm Res; 2004 Jul; 53(7):277-83. PubMed ID: 15241561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with granulocyte-colony-stimulating factor.
    Hubel K; Rodger E; Gaviria JM; Price TH; Dale DC; Liles WC
    Transfusion; 2005 Dec; 45(12):1876-89. PubMed ID: 16371040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte adsorptive apheresis for leg ulcers complicated by rheumatoid arthritis: a report on three successfully treated cases.
    Mori S; Nagashima M; Yoshida K; Yoshino K; Aoki M; Kawana S; Hirata I; Saniabadi A; Yoshino S
    Int J Dermatol; 2004 Oct; 43(10):732-5. PubMed ID: 15485529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective leukocyte apheresis for the treatment of inflammatory bowel disease.
    Abreu MT; Plevy S; Sands BE; Weinstein R
    J Clin Gastroenterol; 2007; 41(10):874-88. PubMed ID: 18090155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte concentrates: prolonged functional capacity during storage in the presence of phenotypic changes.
    Drewniak A; Boelens JJ; Vrielink H; Tool AT; Bruin MC; van den Heuvel-Eibrink M; Ball L; van de Wetering MD; Roos D; Kuijpers TW
    Haematologica; 2008 Jul; 93(7):1058-67. PubMed ID: 18508794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.